<DOC>
	<DOCNO>NCT00763009</DOCNO>
	<brief_summary>The primary objective study understand different people respond differently medication Persantine . The effect Persantine evaluate perform echocardiogram , blood test measure flow blood artery heart patient undergo clinically indicate percutaneous coronary intervention .</brief_summary>
	<brief_title>Persantine : Variation Response Trial</brief_title>
	<detailed_description>Participants receive three dos Persantine intravenously research study . Before receive Persantine dos , patient echocardiogram coronary artery blood flow measure . Blood test , measure function adenosine transporter . In addition variation gene adenosine transporter evaluate .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<criteria>Patients &gt; 21 year old Patient undergoing cardiac catheterization plan PTCA significant coronary lesion either LAD Circumflex Theophylline oral Persantine use 24hrs Second third degree AV block , sick sinus syndrome without function pacemaker Active asthma bronchospasm Patients severe hepatic insufficiency Patients experience acute transmural infarction time index visit Conditions know affect resistive vessel function myocardial flow</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>